首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   70159篇
  免费   6394篇
  国内免费   5105篇
耳鼻咽喉   426篇
儿科学   728篇
妇产科学   892篇
基础医学   8772篇
口腔科学   1202篇
临床医学   9434篇
内科学   10616篇
皮肤病学   782篇
神经病学   3674篇
特种医学   2450篇
外国民族医学   41篇
外科学   7140篇
综合类   12161篇
现状与发展   18篇
一般理论   2篇
预防医学   4312篇
眼科学   1839篇
药学   7520篇
  78篇
中国医学   3740篇
肿瘤学   5831篇
  2024年   238篇
  2023年   1219篇
  2022年   2925篇
  2021年   3671篇
  2020年   2658篇
  2019年   2400篇
  2018年   2411篇
  2017年   2094篇
  2016年   2089篇
  2015年   3175篇
  2014年   3992篇
  2013年   3317篇
  2012年   4868篇
  2011年   5743篇
  2010年   3302篇
  2009年   2518篇
  2008年   3471篇
  2007年   3573篇
  2006年   3644篇
  2005年   3471篇
  2004年   2247篇
  2003年   2219篇
  2002年   1842篇
  2001年   1701篇
  2000年   1778篇
  1999年   1975篇
  1998年   1255篇
  1997年   1349篇
  1996年   1013篇
  1995年   894篇
  1994年   774篇
  1993年   492篇
  1992年   606篇
  1991年   523篇
  1990年   446篇
  1989年   395篇
  1988年   325篇
  1987年   286篇
  1986年   252篇
  1985年   175篇
  1984年   102篇
  1983年   71篇
  1982年   39篇
  1981年   52篇
  1980年   28篇
  1979年   38篇
  1970年   1篇
  1963年   1篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
颈椎Modic改变与轴性疼痛的关系   总被引:1,自引:0,他引:1  
目的:探讨颈椎病患者椎体终板Modic改变的发病情况及临床价值.方法:回顾分析136例颈椎病患者的颈椎MRI矢状位图像资料,记录椎体终板Modic改变的发生率、类型、各节段分布及各分布节段类型,统计并分析Modic改变与颈部轴性疼痛的关系.结果:136例颈椎病患者中有23例存在Modic改变.发生率为16.9%;男性患者中发生率为17.7%,女性为15%;最常出现Modic改变的节段为C56;Modic Ⅰ型、Ⅱ型和Ⅲ型的发生率分别为4.4%、7.4%、5.1%.存在Modic改变的患者中.轴性疼痛发生率为56.5%.术后缓解率为76.9%;无Modic改变者轴性疼痛的发生率为20.4%,术后缓解率为73.9%,两者轴性疼痛发生率有显著性差异(PO.05).Modic改变Ⅰ、Ⅱ、Ⅲ型患者中轴性疼痛发生率分别为83.3%、60%和28.6%,术后缓解率分别为100%、66.7%和50%;Modic改变I型患者轴性疼痛发生率和术后缓解率均较其他两型为高(P相似文献   
992.
目的:探讨复原髋臼窝在CroweⅢ型髋关节发育不良(DDH)精准全髋置换中的作用,以及在标准骨盆X线平片上首次采用量化评分方法评价髋关节假体安装质量的可行性。方法:回顾性研究。纳入2014年3月—2019年4月蚌埠医学院第一附属医院行人工全髋关节置换术治疗的CroweⅢ型DDH终末期骨性关节炎患者86例(92髋),其中...  相似文献   
993.
The emerging cell membrane (CM)-camouflaged poly(lactide-co-glycolide) (PLGA) nanoparticles (NPs) (CM@PLGA NPs) have witnessed tremendous developments since coming to the limelight. Donning a novel membrane coat on traditional PLGA carriers enables combining the strengths of PLGA with cell-like behavior, including inherently interacting with the surrounding environment. Thereby, the in vivo defects of PLGA (such as drug leakage and poor specific distribution) can be overcome, its therapeutic potential can be amplified, and additional novel functions beyond drug delivery can be conferred. To elucidate the development and promote the clinical transformation of CM@PLGA NPs, the commonly used anucleate and eukaryotic CMs have been described first. Then, CM engineering strategies, such as genetic and nongenetic engineering methods and hybrid membrane technology, have been discussed. The reviewed CM engineering technologies are expected to enrich the functions of CM@PLGA for diverse therapeutic purposes. Third, this article highlights the therapeutic and diagnostic applications and action mechanisms of PLGA biomimetic systems for cancer, cardiovascular diseases, virus infection, and eye diseases. Finally, future expectations and challenges are spotlighted in the concept of translational medicine.  相似文献   
994.
With the need of developing new materials, exploring new phenomenon, and discovering new mechanisms under extreme conditions, the response of materials to high-pressure compression attract more attention. However, the high-pressure state deviating from the Hugoniot line is difficult to realize by conventional experiments. Gas gun launching graded materials could reach the state. In our work, the corresponding Al-Cu composites and graded materials are prepared by tape casting and hot-pressing sintering. The microstructure and the acoustic impedance of the corresponding Al-Cu composites are analyzed to explain the impact behavior of Al-Cu graded materials. Computed tomographic testing and three-dimension surface profilometry machine results demonstrated well-graded structure and parallelism of the graded material. Al-Cu GMs with good parallelism are used to impact the Al-LiF target at 2.3 km/s using a two-stage light-gas gun, with an initial shock impact of 20.6 GPa and ramping until 27.2 GPa, deviating from the Hugoniot line.  相似文献   
995.
To deeply understand the adsorption process of oxygen on the surface of a plutonium gallium system and to reveal the chemical reaction mechanism at the initial stage of oxidative corrosion on the surface of plutonium gallium alloy at a theoretical level, the adsorption behavior of oxygen molecules on the surface of a plutonium gallium system was investigated by a first-principles approach based on density flooding theory. The results show that the molecular bond length increases and finally breaks when the surface oxygen molecule is adsorbed on the surface of plutonium gallium system and dissociates into two atomic states. The most likely adsorption position of oxygen molecules on the surface of plutonium gallium system is hole-site vertical adsorption with the adsorption energy size of 10.7 eV. The bonding between oxygen atom and surface is mainly due to the overlapping hybridization of Pu-6s, Pu-7s, Pu-6d, Ga-3d and O-2p orbitals. Oxygen molecules mainly interact with the atoms of the first layer on the surface of the plutonium gallium system. The oxygen atoms after stable adsorption are able to diffuse to the subsurface of the plutonium gallium system after overcoming the energy barrier of 16.7 eV and form a stable structure. The research results reveal the initial reaction process and adsorption law of oxygen on the surface of plutonium gallium system from microscopic level, which is helpful to further explore the surface corrosion prevention technology of plutonium gallium system and improve the reliability and safety of plutonium gallium alloy components.  相似文献   
996.
摘 要 目的:建立益安宁丸的HPLC指纹图谱,并测定5种主要成分(人参皂苷Rg1、人参皂苷Rb1、三七皂苷R1、五味子酯甲和丹参酮ⅡA)的含量,为益安宁丸的质量控制提供可靠方法。 方法: 采用Waters Sunfire TM C18色谱柱(250 mm×4.6 mm,5 μm),以乙腈(A) 0.1%磷酸水溶液(B)为流动相,梯度洗脱(0~5 min,2% A;5~15 min,2%A→10%A;15~25 min,10%A→30%A;25~40 min,30% A;40~60 min,30% A→90% A;60~70 min,90% A);流速为1.0 ml·min-1;检测波长为203 min(0~60 min,检测人参皂苷Rg1、人参皂苷Rb1、三七皂苷R1和五味子酯甲)、270 nm(60~70 min,检测丹参酮ⅡA);柱温35 ℃。 结果: 在指纹图谱研究中,共确定益安宁丸HPLC指纹图谱26个共有峰,通过与混合对照品比较指认其中7个指标成分,分别是6号 五味子酯甲、16号 人参皂苷Rg1、17号 人参皂苷Rb1、18号 三七皂苷R1、23号 丹参酮Ⅰ、24号 五味子甲素和26号 丹参酮ⅡA,利用相似度软件对14批样品指纹图谱进行分析,各批样品相似度均在0.98以上。在建立的色谱条件下试验5个成分分离度良好,方法精密度和重复性RSD值均<1.5%,供试品溶液在24 h内稳定,各成分具有良好的线性关系和较宽线性范围;6批益安宁丸中人参皂苷Rg1、人参皂苷Rb1、三七皂苷R1、五味子酯甲和丹参酮ⅡA质量分数分别在7.187 0~7.254 0,9.086 0~9.250 0,2.109 0~2.288 0,11.208 0~11.338 0和1.374 0~1.458 0 mg·g-1。 结论: 所建立的益安宁丸HPLC指纹图谱检测和定量测定分析方法快速、准确,可以有效地评价益安宁丸的质量。  相似文献   
997.
抗生素西索米星发酵过程中次要组分的调控   总被引:2,自引:2,他引:2  
在西索米星产生菌橄榄星孢小单孢菌M-41的发酵代谢与产物合成的研究中,发现通过控制种子期菌丝的生长形态、培养基中磷酸盐含量,并在发酵过程中添加合适的抑制剂,可有效地减少发酵液中次要组分verdamicin的生物合成,增加主要组分西索米星的含量。  相似文献   
998.
BSA-loaded mcirospheres were prepared by a modified phase separation method, in which petroleum ether (PE) containing a certain amount of Span 80 rather than poly (dimethylsiloxane) (PDMS) was adopted as coacervating agent. Process parameters such as Span 80 concentration, the volume and addition rate of coacervating agent, polymer concentration, agitation rate during the phase separation process and PE type were evaluated to optimize the protein encapsulation. It was found microspheres with high yield (>80.0%) and entrapment efficiency (>90%) could be obtained using PE containing 5.0% Span 80 as the coacervating agent. Microspheres with small particle size (<10?µm) could be produced successfully with appropriate process parameters. In vitro release study suggested that burst release was significantly influenced by Span 80 concentration, polymer concentration and PE type and the burst release could be reduced to <20% with optimized formulation. A biphasic release behavior in vitro test was observed for the microspheres prepared by this method. GC analysis demonstrated that residual solvent of DCM and petroleum ether was decreased dramatically in comparison with PDMS used as a conventional coacervating agent.  相似文献   
999.
加兰他敏治疗阿尔茨海默病作用机制的研究进展   总被引:13,自引:0,他引:13  
阿尔茨海默病是老年性痴呆中最常见的一种类型。加兰他敏作为第二代乙酰胆碱酯酶抑制剂,原用于治疗重症肌无力和小儿麻痹后遗症等疾病,近年来被应用于临床治疗阿尔茨海默病.效果明显。本文就加兰他敏治疗阿尔茨海默病作用机制的最新研究情况作一简要概述。  相似文献   
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号